CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 87 filers reported holding CUREVAC N V in Q4 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $89,551 | -39.7% | 21,271 | -2.2% | 0.06% | -43.0% |
| Q3 2023 | $148,607 | +24.1% | 21,758 | +89.3% | 0.11% | +44.3% |
| Q2 2023 | $119,747 | +39.1% | 11,492 | -7.0% | 0.08% | +31.7% |
| Q1 2023 | $86,086 | +14.8% | 12,351 | -1.0% | 0.06% | -3.2% |
| Q4 2022 | $75,000 | -24.2% | 12,482 | -0.9% | 0.06% | -26.2% |
| Q3 2022 | $99,000 | -40.7% | 12,598 | +2.9% | 0.08% | +121.1% |
| Q2 2022 | $167,000 | -40.8% | 12,247 | +136.9% | 0.04% | -80.5% |
| Q3 2021 | $282,000 | -15.6% | 5,170 | +13.8% | 0.20% | -14.1% |
| Q2 2021 | $334,000 | – | 4,545 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,625,943 | $16,942,326 | 13.48% |
| RA Capital Management | 12,245,955 | $127,602,851 | 2.41% |
| Avidity Partners Management LP | 4,300,000 | $44,806,000 | 1.56% |
| Camber Capital Management LP | 1,462,500 | $15,239 | 0.50% |
| Eversept Partners, LP | 357,342 | $3,723,504 | 0.31% |
| Ghisallo Capital Management LLC | 100,000 | $1,042,000 | 0.12% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 226,134 | $2,356,316 | 0.08% |
| Green Alpha Advisors, LLC | 11,492 | $119,747 | 0.08% |
| Alyeska Investment Group, L.P. | 899,423 | $9,371,988 | 0.07% |
| Virtus ETF Advisers LLC | 10,692 | $111,411 | 0.07% |